EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

L‐carnitine alleviates cardiac microvascular dysfunction in diabetic cardiomyopathy by enhancing PINK1‐Parkin ‐dependent mitophagy through the CPT1a‐PHB2‐PARL pathways

Su Li iD, Muyin Liu, Jinxiang Chen, Yuqiong Chen, Ming Yin, You Zhou, Qiyu Li, Fei Xu, Youran Li, Xiaopei Yan, Yan Xia, Ao Chen und 6 weitere

Acta Physiologica · 2023-07 · 238 (3)

DOI: 10.1111/apha.13975 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Physiologica, online erschienen am 30.04.2023. Verfasst von Su Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Diabetes Mellitus. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To explore the beneficial effects of L‐carnitine on cardiac microvascular dysfunction in diabetic cardiomyopathy from the perspectives of mitophagy and mitochondrial integrity.

Methods

Male db/db and db/m mice were randomly assigned to groups and were treated with L‐carnitine or a solvent for 24 weeks. Endothelium‐specific PARL overexpression was attained via adeno‐associated virus serotype 9 (AAV9) transfection. Adenovirus (ADV) vectors overexpressing wild‐type CPT1a, mutant CPT1a, or PARL were transfected into endothelial cells exposed to high glucose and free fatty acid (HG/FFA) injury. Cardiac microvascular function, mitophagy, and mitochondrial function were analyzed by immunofluorescence and transmission electron microscopy. Protein expression and interactions were assessed by western blotting and immunoprecipitation.

Results

L‐carnitine treatment enhanced microvascular perfusion, reinforced endothelial barrier function, repressed the endothelial inflammatory response, and maintained the microvascular structure in db/db mice. Further results demonstrated that PINK1‐Parkin‐dependent mitophagy was suppressed in endothelial cells suffering from diabetic injury, and these effects were largely alleviated by L‐carnitine through the inhibition of PARL detachment from PHB2. Moreover, CPT1a modulated the PHB2‐PARL interaction by directly binding to PHB2. The increase in CPT1a activity induced by L‐carnitine or amino acid mutation (M593S) enhanced the PHB2‐PARL interaction, thereby improving mitophagy and mitochondrial function. In contrast, PARL overexpression inhibited mitophagy and abolished all the beneficial effects of L‐carnitine on mitochondrial integrity and cardiac microvascular function.

Conclusion

L‐carnitine treatment enhanced PINK1‐Parkin‐dependent mitophagy by maintaining the PHB2‐PARL interaction via CPT1a, thereby reversing mitochondrial dysfunction and cardiac microvascular injury in diabetic cardiomyopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesDiabetes MellitusMiceMaleAnimalsMitophagyEndothelial CellsCarnitineProtein KinasesUbiquitin-Protein Ligases

Stichwörter der Autor:innen

L-carnitinePARLPHB2cardiac microvascular dysfunctiondiabetes mellitusmitophagy

Substanzen

CarnitineProtein KinasesUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
  • National Clinical Research Center for Interventional Medicine, Shanghai, China.
  • Shanghai Clinical Research Center for Interventional Medicine, Shanghai, China.
  • Department of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.

ORCID-Profile: Su Li

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Li, S., Liu, M., Chen, J., Chen, Y., Yin, M., Zhou, Y., Li, Q., Xu, F., Li, Y., Yan, X., Xia, Y., Chen, A., Lu, D., Li, C., Shen, L., Chen, Z., Qian, J., & Ge, J. (2023). L‐carnitine alleviates cardiac microvascular dysfunction in diabetic cardiomyopathy by enhancing PINK1‐Parkin ‐dependent mitophagy through the CPT1a‐PHB2‐PARL pathways. Acta Physiologica, 238(3). https://doi.org/10.1111/apha.13975

Vancouver

Li S, Liu M, Chen J, Chen Y, Yin M, Zhou Y, et al. L‐carnitine alleviates cardiac microvascular dysfunction in diabetic cardiomyopathy by enhancing PINK1‐Parkin ‐dependent mitophagy through the CPT1a‐PHB2‐PARL pathways. Acta Physiologica. 2023;238(3). doi:10.1111/apha.13975

BibTeX
@article{Li2023,
  author = {Li, Su and Liu, Muyin and Chen, Jinxiang and Chen, Yuqiong and Yin, Ming and Zhou, You and Li, Qiyu and Xu, Fei and Li, Youran and Yan, Xiaopei and Xia, Yan and Chen, Ao and Lu, Danbo and Li, Chenguang and Shen, Li and Chen, Zhangwei and Qian, Juying and Ge, Junbo},
  title = {L‐carnitine alleviates cardiac microvascular dysfunction in diabetic cardiomyopathy by enhancing PINK1‐Parkin ‐dependent mitophagy through the CPT1a‐PHB2‐PARL pathways},
  journal = {Acta Physiologica},
  year = {2023},
  volume = {238},
  number = {3},
  doi = {10.1111/apha.13975}
}
Kostenlos starten →